The University of Queensland Homepage
Diamantina Institute Homepage You are at the Development website

Multiple Sclerosis

Did you know?

Multiple sclerosis (MS) is a common chronic disorder that usually affects people during the prime of their lives. This progressive and unpredictable disease affects the nervous system and there is currently no cure.

MS occurs when the protective sheath that surrounds the nerve fibres in the brain and spinal cord, called myelin, becomes damaged. This is known as demyelination. This process impairs the conduction of signals in the affected nerves, causing impairment in sensation, movement, cognition or other functions depending on which nerves are affected. The human brain has an estimated 100 billion neurons, all which make many connections with each other. As a result of this complexity, symptoms of MS are unpredictable and highly variable between patients. The more common symptoms include blurred vision, numbness, muscle weakness, loss of balance, extreme fatigue and hand tremors.

Our immune system normally protects us against disease by attacking foreign invaders like bacteria and viruses. However in MS, the immune system begins attacking the myelin sheath, resulting in demyelination. Although many risk factors for MS have been identified, the trigger for this immune system attack has not yet been identified. Genetics and environmental factors, such as viruses, are considered to be involved. Although MS is not considered to be a hereditary disease, genes related to susceptibility are thought to play a part, since there is a great variation in occurrence of MS in different racial groups.

Twice as many women as men have multiple sclerosis, with the onset of symptoms occurring most often between the ages of 20 and 40 years.


Diamantina’s research into multiple sclerosis

Researchers at the Musculoskeletal Genetics Group are investigating what genes contribute to the risk of developing MS. Until recently, identifying those genes was a nearly impossible task. The development of genome-wide association studies, in which thousands of genes are examined in thousands of patients and healthy subjects, has revolutionised this field. Our group is extremely active in this cutting-edge area. We are currently performing genome-wide association studies in a number of diseases, including MS. We expect to find novel genes and genetic regions involved in the development of the disease, providing vital information for biologists as to definite components of the jigsaw of elements that lead to human disease.

More information

For more detailed information about the research that is being done in the Musculoskeletal Genetics Group, click on the link. For more information about skin cancer, we recommend you visit the MS Society website.